Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Endothelial to mesenchymal Notch signaling regulates skeletal repair
Sanja Novak, Hitoshi Tanigawa, Vijender Singh, Sierra H. Root, Tannin A. Schmidt, Kurt D. Hankenson, Ivo Kalajzic
Sanja Novak, Hitoshi Tanigawa, Vijender Singh, Sierra H. Root, Tannin A. Schmidt, Kurt D. Hankenson, Ivo Kalajzic
View: Text | PDF
Research Article Bone biology

Endothelial to mesenchymal Notch signaling regulates skeletal repair

  • Text
  • PDF
Abstract

We present a transcriptomic analysis that provides a better understanding of regulatory mechanisms within the healthy and injured periosteum. The focus of this work is on characterizing early events controlling bone healing during formation of periosteal callus on day 3 after fracture. Building on our previous findings showing that induced Notch1 signaling in osteoprogenitors leads to better healing, we compared samples in which the Notch 1 intracellular domain is overexpressed by periosteal stem/progenitor cells, with control intact and fractured periosteum. Molecular mechanisms and changes in skeletal stem/progenitor cells (SSPCs) and other cell populations within the callus, including hematopoietic lineages, were determined. Notably, Notch ligands were differentially expressed in endothelial and mesenchymal populations, with Dll4 restricted to endothelial cells, whereas Jag1 was expressed by mesenchymal populations. Targeted deletion of Dll4 in endothelial cells using Cdh5CreER resulted in negative effects on early fracture healing, while deletion in SSPCs using α-smooth muscle actin–CreER did not impact bone healing. Translating these observations into a clinically relevant model of bone healing revealed the beneficial effects of delivering Notch ligands alongside the osteogenic inducer, BMP2. These findings provide insights into the regulatory mechanisms within the healthy and injured periosteum, paving the way for novel translational approaches to bone healing.

Authors

Sanja Novak, Hitoshi Tanigawa, Vijender Singh, Sierra H. Root, Tannin A. Schmidt, Kurt D. Hankenson, Ivo Kalajzic

×

Figure 5

Deletion of Dll4 in ECs impairs fracture healing.

Options: View larger image (or click on image) Download as PowerPoint
Deletion of Dll4 in ECs impairs fracture healing.
(A) Experimental desig...
(A) Experimental design. Deletion of Dll4 in ECs was induced by injecting tamoxifen (Tx) at 0, 2, and 4 dpf. Fractured bone samples were evaluated on day 4, 7, and 14 by histology and day 21 by microCT and torsion testing. (B) Dll4 deletion led to a decreased callus size at 4 dpf (Cre– n = 6, Cre+ n = 9), 7 dpf (Cre– n = 9, Cre+ n = 8), and 14 dpf (Cre– n = 8, Cre+ n = 10). (C) Dll4 deletion also resulted in decreased proliferation at 4 dpf (Cre– n = 5, Cre+ n = 9), which increased by 7 dpf (Cre– n = 9, Cre+ n = 8) in Cre+ compared with Cre– animals. (D and F) Cre+ mice had significantly less cartilage. Sample numbers at 4 dpf (Cre– n = 5, Cre+ n = 9), 7 dpf (Cre– n = 9, Cre+ n = 8), and 14 dpf (Cre– n = 8, Cre+ n = 10) were analyzed by evaluating Safranin O–stained sections, as observed on representative sections. (E and G) Mineralized area was analyzed by von Kossa staining (Cre– n = 8, Cre+ n = 10), as shown on Cre- and Cre+ representative sections. (H) MicroCT analysis showed decreased callus bone mass on day 14 and no difference in callus volume, with representative 3D reconstructions of Cre– and Cre+ fractures on the right. At 7 dpf, Cre– n = 8, Cre+ n = 6; and at 21 dpf Cre– n = 7, Cre+ n = 9. (I) Biomechanical properties were evaluated by torsion testing and are presented as bone strength (maximum torque), stiffness as a measure of torsional rigidity, and toughness as a work to fracture measure, with no change between Cre– and Cre+ fractured bones at 21 dpf. Cre– n = 9, Cre+ n = 6. (J) Bglap gene expression analysis at 7 dpf (Cre– n = 6, Cre+ n = 6). (K) Histological analysis of osteocalcin-stained samples at 14 dpf (Cre– n = 8, Cre+ n = 10). (L) Evaluation of CD31+ cells within the periosteal callus at 7 dpf (Cre– n = 9, Cre+ n = 12) and 14 dpf (Cre– n = 7, Cre+ n = 9). Deletion of Dll4 in ECs with (M) representative magnified images of CD31 staining within the mineralized callus at 14 dpf. Scale bar: 200 μm. (N) Proportion of osterix-stained cells within the periosteal callus (Cre– n = 5, Cre+ n = 6). (O) Representative images of osterix-stained fractured femurs with magnified areas of cartilaginous callus (a and b), mineralized callus (a’ and b’), and cortical bone with the area next to the pin insertion (a” and b”). The analyzed periosteal callus is shown by the yellow line. Scale bars: 1 mm (left) and 100 μm (right). PT, pin trace; CB, cortical bone; P, periosteum. Unpaired, 2-tailed Student’s t test. *P < 0.05, **P < 0.01.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts